#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiomyopathy Factor VIII deficiency Bone marrow disorder Astrocytoma malignant Marfan's syndrome Diabetes insipidus Immune-mediated renal disorder Leukocyte adhesion deficiency type I Sarcoidosis Cholestatic pruritus Richter's syndrome Porphyria non-acute Prader-Willi syndrome Pleomorphic leiomyosarcoma Myocarditis More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome – Diagnostics Antithrombin III deficiency – Life with Disease MELAS syndrome – Basic Information Familial haemophagocytic lymphohistiocytosis KBG syndrome – Basic Information Noonan syndrome – Trials in Disease Amyotrophic lateral sclerosis – Basic Information Combined immunodeficiency – Life with Disease Paroxysmal nocturnal haemoglobinuria – Treatment Urea cycle disorder – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diclofenac Diethylamine Abc-15Bo-116 Soft Paraffin And Fat Products Tigecycline Acetylsalicylic Acid Ph. Eur. Phenylalanine HUMAN THROMBIN Cefoxitin Tertomotide Dicloxacillin Azd8205 Messenger Rna Encoding Cas9 CC-97540 Ly3871801 Izorlisib Mesilate INCB123667 Obinutuzumab XMAB942 Amantadine Hydrochloride ANHYDROUS CALCIUM FOLINATE More therapies…

    Learn about Your Condition

    Biliary tract operation Metabolic surgery Heart transplant Bile duct cancer Haemodynamic instability Pulmonary resection Gastrooesophageal cancer Genitourinary tract neoplasm Exfoliation glaucoma Biliary cancer metastatic Connective tissue disorder Triple positive breast cancer Chorea Apathy Anogenital dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Effects of Intravenous Ferric Derisomaltose in Non-Anemic Iron Deficient Patients with Colorectal Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Ferric Derisomaltose
    • Sodium Chloride
    Denmark

  • Study of Radioembolization Combined with Cisplatin, Gemcitabine and Durvalumab Treatment in Patients with Unresectable Liver Cholangiocarcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Investigated Drugs:
    • Cisplatin
    • Durvalumab
    • Gemcitabine
    Italy

  • Study on Pressurized Intraperitoneal Aerosol Chemotherapy with Fluorouracil for Patients with Gastric Cancer with Peritoneal Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma gastric
    Investigated Drugs:
    • Calcium Levofolinate
    • Cisplatin
    • Docetaxel
    Italy

  • Study of Durvalumab and Tremelimumab for Patients with Resectable Liver Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Durvalumab
    • Tremelimumab
    Italy Spain

  • Study on Post-Surgery Antibiotic Use in Patients with Complicated Acute Appendicitis: Evaluating Metronidazole, Ceftriaxone, and Ofloxacin Hydrochloride

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ceftriaxone Sodium
    • Glucose
    • Lidocaine Hydrochloride
    France

  • Study on Pain Relief for Patients with Inguinal Hernia: Comparing Ropivacaine Hydrochloride TAP Block and Sodium Chloride Local Infiltration

    Recruiting

    3 1 1
    Investigated Diseases:
    • Inguinal hernia
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride
    Belgium
Previous Page
1 … 27 28 29 30 31 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!